These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1511443)

  • 1. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression.
    Aldaz CM; Chen A; Gollahon LS; Russo J; Zappler K
    Cancer Res; 1992 Sep; 52(17):4791-8. PubMed ID: 1511443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression.
    Aldaz CM; Liao QY; Paladugu A; Rehm S; Wang H
    Mol Carcinog; 1996 Nov; 17(3):126-33. PubMed ID: 8944072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic HRAS amplification in ovary-independent mammary tumors: correlation with progressively anaplastic phenotypes.
    Aldaz CM; Gollahon LS; Chen A
    Cancer Res; 1993 Nov; 53(22):5339-44. PubMed ID: 8221670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
    Haag JD; Hsu LC; Newton MA; Gould MN
    Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
    Mayr B; Dressler A; Reifinger M; Feil C
    Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice.
    Weaver ZA; McCormack SJ; Liyanage M; du Manoir S; Coleman A; Schröck E; Dickson RB; Ried T
    Genes Chromosomes Cancer; 1999 Jul; 25(3):251-60. PubMed ID: 10379871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection.
    Ichikawa T; Kyprianou N; Isaacs JT
    Cancer Res; 1990 Oct; 50(19):6349-57. PubMed ID: 2119253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal changes associated with progression of the Dunning R-3327 rat prostatic adenocarcinoma system.
    Wake N; Isaacs J; Sandberg AA
    Cancer Res; 1982 Oct; 42(10):4131-42. PubMed ID: 7105009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
    Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
    Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
    Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
    Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression.
    Sargent L; Dragan YP; Babcock K; Wiley J; Klaunig J; Pitot HC
    Cancer Res; 1996 Jul; 56(13):2992-7. PubMed ID: 8674053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
    Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
    Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
    Ritland SR; Rowse GJ; Chang Y; Gendler SJ
    Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene amplification in the proximal part of chromosome 6 in rat endometrial adenocarcinoma as revealed by combined BAC/PAC FISH, chromosome painting, zoo-FISH, and allelotyping.
    Adamovic T; Trossö F; Roshani L; Andersson L; Petersen G; Rajaei S; Helou K; Levan G
    Genes Chromosomes Cancer; 2005 Oct; 44(2):139-53. PubMed ID: 15942940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
    Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
    Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Ras mutations in rat DMBA-induced mammary tumors.
    Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
    Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.